Web
|
Images
|
News
News Home
US
World
Business
Finance
Industry
Technology
Science
Media & Advertising
Politics/Law
Entertainment
Internet
Health
Sports
Culture
Log In
CoLucid Pharmaceuticals Announces $25 Million Series B Financing for Advancement
Have an interest in this Story?
Sign Up for Real-Time email updates
Healthcare Sales & Marketing Network
|
July 07, 2008
INDIANAPOLIS, July 1 (HSMN NewsFeed) -- CoLucid Pharmaceuticals, Inc., an innovative biotechnology company focusing on therapies for central nervous system disorders, announced it closed a $25 million Series B financing. New investor Care Capital led the round, which included previous investors Papp...
Read Full Article
Leave a Comment:
You must be logged in to leave a comment
Log in
|
Register
Most Read World Articles
Shoplifting suspect crushed in compactor
- Grand Haven Tribune
A Spirited Debate On A Lower Drinking Age
- CBS News
"Fay" Finds Florida
- WAWS FOX30
Gary Glitter released from prison in Vietnam
- Belfast Telegraph
Whale calf mistakes boat for mum
- ITV.com
Featured Members
Alexandr Migunov
Consultant
Real Estate Industry
Jaime Neyra Morales
Relationship Manager, Commercial Banking
Banking
View more profiles
Access dozens of premium and subscriptions sites
Free!
Download now
.
Advertise
|
Build a News Circle
|
Get News Briefings
|
Congoo News Home
|
Get the Netpass
About Congoo
|
Terms
|
Privacy
|
Need Help?
|
Site Map
Copyright ©2008 Congoo.com. All Rights Reserved.